Gproan Biotech Inc is a synthetic biology company established in 2006. Comprised of experienced and dedicated scientists, Gproan Biotech is committed to developing and producing innovative products and technologies to support global life science research. They specialize in delivering high-quality and value-priced recombinant enzymes and recombinant virus-like particle vaccines.

Gproan Biotech offers a wide range of products, including recombinant enzymes such as Proteinase K, Binuclease RNase A, Glucose Dehydrogenase, and Glucose Oxidase. They also provide VLP (virus-like particle) vaccines, including HPV vaccines, HFMD vaccines, combined vaccines against Hepatitis C and E, and Influenza vaccines. The company applies unique protein engineering technologies, large-scale eukaryotic cell culture, and fermentation platforms to produce their products.

Their recombinant baculovirus expression system and optimized suspension insect cell culture enable them to generate highly immunogenic vaccines. Gproan Biotech has a research center in Beijing, Gproan Protein Engineering, which focuses on the development of recombinant protein products. They also have Gproan Biotech Jiangsu Co., Ltd, located in Taicang Biomedical Industrial Park, Jiangsu province, China.

With their expertise and innovative solutions, Gproan Biotech is dedicated to meeting the needs of their customers in the field of biotechnology research and production